Overview
Salaries
Products
People
Growth
Offices
Financials

Funding and backers

Backers
1
Inveready
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2024 Founded
Backed byfrom the funds' portfolios and accelerator catalogs
Similar startupsby what they do, their industry and backers
Khumbu.ai51-200 employees
AI-first biotech accelerating early drug discovery with protein–ligand insights and advanced models for molecular understanding. Khumbu.ai.
Ring Therapeutics51-200 employees • 2 roles
Ring Therapeutics is a biotechnology company creating novel vector conjugate medicines that carry more and reach further, expanding…
Alloy Therapeutics51-200 employees • 8 roles
Alloy Therapeutics democratizes access to antibody discovery and biologics discovery technology to enable and advance drug discovery in…
MOLCUREFounded 2019 • 11-50 employees • 2 roles
Molcure Inc. is an AI company focusing on accelerating drug discovery through the combination machine learning, biotechnology, and robotics.
KiloGen Therapeutics specializes in proximity pharmacology, molecular glues, targeted protein degradation (TPD), biotechnology, drug…
relay_tx9 roles
Relay Therapeutics® puts protein motion at the heart of drug discovery to dramatically expand therapeutic possibilities.

Overview

ABOUT US IteriaBiopharma is a privately owned Spanish biotech founded in 2024 by a team of experienced entrepreneurs in drug discovery and development.